In contrast, the rHDL-0 group exhibited higher AST and ALT levels than the CML + rHDL-1 group, approximately 404 IU/L and 257 IU/L, respectively. The gene discussed is GPT; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.